15 Mar 2016

Updated information about Stamaril® yellow fever vaccine

Updated information about Stamaril® yellow fever vaccine has been published by the manufacturer Sanofi Pasteur MSD Updated information about Stamaril® yellow fever vaccine

On 3 February 2016 updated information about Stamaril® yellow fever vaccine was published by the manufacturer Sanofi Pasteur MSD, in the form of a Summary of Product Characteristics (SmPC) and Patient Information Leaflet (PIL).

SPC’s are written and updated by pharmaceutical companies based on their research/ product knowledge and explain how to prescribe and use a medication for health professionals.  The PIL is the leaflet that is included in the pack with a medicine, written by the pharmaceutical company and is a patient-friendly version of the SPC. SPC’s and PILs are available on the electronic Medicines Compendium.

Advice for travellers

Travellers visiting yellow fever areas should review the updated PIL for their own information and discuss the issues around yellow fever with their health care provider.

Advice for health professionals

Health professionals advising travellers about yellow fever vaccine should review the updated SPC as there have been a number of changes to the current edition.

Resources

   

Changes to advice line opening hours

Advice line hours are changing from 1st February 2021 Read more

COVID-19: Vaccination

A UK wide vaccination programme is now in progress for priority groups Read more

COVID-19: advice for Humanitarian Aid workers

Advice for UK humanitarian aid workers deployed overseas during COVID-19 pandemic Read more

Umrah 2020/1442H: some restrictions eased for pilgrims

A staged approach to ease current restrictions is planned Read more

Resuscitation Council UK publish anaphylaxis guidance for vaccination providers

Updated information for health professionals involved in vaccination programmes Read more
Back to Top

VIEW FULL INDEX